WHD Q1 2026 Earnings EPS Beats Estimates by 861 Stock Edges Higher MVST Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Operational Challenges aTyr Pharma Q1 2026 Earnings NarrowerThanExpected Loss Provides Some Relief Amid Pipeline Development C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage KURA Q1 2026 Earnings WiderThanExpected Loss Amid Clinical Progress IVVD Q1 2026 Earnings WiderthanExpected Loss Amid Continued Pipeline Development